Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

5.92
Delayed Data
As of 10:47am ET
 +0.01 / +0.17%
Today’s Change
4.38
Today|||52-Week Range
7.16
+3.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues49.2M72.5M63.1M67.4M
 
 
 
 
 
Cost of Goods Sold16.2M14.5M8.1M12.2M
 
 
 
 
 
Depreciation And Amortization4.5M6.7M8.4M6.2M
 
 
 
 
 
 
Operating ExpensesGross Income28.5M51.3M46.6M49.0M
 
 
 
 
 
General Expenses48.0M42.4M46.2M46.9M
 
 
 
 
 
Research And Development17.2M8.4M11.0M9.5M
 
 
 
 
 
Total Operating Expenses68.7M63.7M62.6M65.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.5M8.8M458.0K2.1M
 
 
 
 
 
Extraordinary Charge---57.0K0.000.00
 
 
Interest Expense On Debt2.2M3.1M3.5M1.9M
 
 
 
 
 
Other Expenses1.1M362.0K1.5M1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.6M8.1M1.1M3.0M
 
 
 
 
 
Income Taxes-883.9K-2.2M-1.5M-2.5M
 
 
 
 
 
Minority Interest-3.9M-2.9M-515.0K-861.0K
 
 
 
 
 
Discontinued Operations0.000.000.00-728.0K
 
 
Net Income-14.9M7.4M-851.0K-1.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS54.9M55.3M55.7M56.3M
 
 
 
 
 
Shares To Calculate EPS Diluted54.9M55.8M55.7M56.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.27$0.13-$0.02-$0.02
 
 
 
 
 
EPS Diluted-$0.27$0.13-$0.02-$0.02